Phenominer Database Results (8 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.5 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98864 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.6 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98859 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.4 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98860 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.6 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98861 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.6 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98863 2160
SD heart left ventricle end-diastolic posterior wall thickness sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.6 mm 0.1 0.24 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98865 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.4 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98858 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male  days 6 1.3 mm 0.1 0.24 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98862 2160